Product Information
PACERONE 400 MG TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.7188 per EA under NDC 00245164501. Its NADAC has been published 109 times since Apr 17, 2024.
Strength
400 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245164501
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075135On Market Since
7/2/2020
Pharmacological Classes
Price Statistics
The NADAC for PACERONE 400 MG TABLET has been published 109 times since Apr 17, 2024, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7188 per EA |
|---|---|
| All-time high | $1.8755 (Jun 12, 2024) |
| All-time low | $0.7188 (May 21, 2025) |
| 52-week high | $0.7188 |
| 52-week low | $0.7188 |
| Median price | $0.7221 |
| Average price | $1.0139 |
| Largest weekly change | -31.8% (Feb 19, 2025) |
| Weeks tracked | 109 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PACERONE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PACERONE 400 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.7188 per EA (NDC 00245164501), effective May 13, 2026.
How has the price of PACERONE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for PACERONE 400 MG TABLET has declined 61.5%. It has been tracked across 109 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PACERONE 400 MG TABLET?
Since Apr 17, 2024, the NADAC for PACERONE 400 MG TABLET has ranged from a low of $0.7188 (May 21, 2025) to a high of $1.8755 (Jun 12, 2024), with a median of $0.7221 per EA.
Are there cheaper alternatives to PACERONE 400 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMIODARONE HCL 400 MG TABLET, is $0.3876 per EA — about 46% below PACERONE 400 MG TABLET.
Who manufactures PACERONE 400 MG TABLET?
PACERONE 400 MG TABLET (NDC 00245164501) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification